440 related articles for article (PubMed ID: 35187675)
1. Skin cancer, including related pathways and therapy and the role of luteolin derivatives as potential therapeutics.
Juszczak AM; Wöelfle U; Končić MZ; Tomczyk M
Med Res Rev; 2022 Jul; 42(4):1423-1462. PubMed ID: 35187675
[TBL] [Abstract][Full Text] [Related]
2. Luteolin, a flavonoid, as an anticancer agent: A review.
Imran M; Rauf A; Abu-Izneid T; Nadeem M; Shariati MA; Khan IA; Imran A; Orhan IE; Rizwan M; Atif M; Gondal TA; Mubarak MS
Biomed Pharmacother; 2019 Apr; 112():108612. PubMed ID: 30798142
[TBL] [Abstract][Full Text] [Related]
3. Plant derived anticancer agents: A green approach towards skin cancers.
Ijaz S; Akhtar N; Khan MS; Hameed A; Irfan M; Arshad MA; Ali S; Asrar M
Biomed Pharmacother; 2018 Jul; 103():1643-1651. PubMed ID: 29864953
[TBL] [Abstract][Full Text] [Related]
4. The Anticancer Activities of Natural Terpenoids That Inhibit Both Melanoma and Non-Melanoma Skin Cancers.
Yoon YE; Jung YJ; Lee SJ
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674007
[TBL] [Abstract][Full Text] [Related]
5. Role of microRNAs in the anticancer effects of the flavonoid luteolin: a systematic review.
Mishan MA; Khazeei Tabari MA; Mahrooz A; Bagheri A
Eur J Cancer Prev; 2021 Sep; 30(5):413-421. PubMed ID: 33720053
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated.
Ganai SA; Sheikh FA; Baba ZA; Mir MA; Mantoo MA; Yatoo MA
Phytother Res; 2021 Jul; 35(7):3509-3532. PubMed ID: 33580629
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Anticancer Potential of
Juszczak AM; Czarnomysy R; Strawa JW; Zovko Končić M; Bielawski K; Tomczyk M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805898
[No Abstract] [Full Text] [Related]
8. Luteolin mediated targeting of protein network and microRNAs in different cancers: Focus on JAK-STAT, NOTCH, mTOR and TRAIL-mediated signaling pathways.
Farooqi AA; Butt G; El-Zahaby SA; Attar R; Sabitaliyevich UY; Jovic JJ; Tang KF; Naureen H; Xu B
Pharmacol Res; 2020 Oct; 160():105188. PubMed ID: 32919041
[TBL] [Abstract][Full Text] [Related]
9. Distribution and biological activities of the flavonoid luteolin.
López-Lázaro M
Mini Rev Med Chem; 2009 Jan; 9(1):31-59. PubMed ID: 19149659
[TBL] [Abstract][Full Text] [Related]
10. Medicinal Plants Towards Modeling Skin Cancer.
El-Harakeh M; Al-Ghadban S; Safi R
Curr Drug Targets; 2021; 22(2):148-161. PubMed ID: 33019926
[TBL] [Abstract][Full Text] [Related]
11. Paving Luteolin Therapeutic Potentialities and Agro-Food-Pharma Applications: Emphasis on
Taheri Y; Sharifi-Rad J; Antika G; Yılmaz YB; Tumer TB; Abuhamdah S; Chandra S; Saklani S; Kılıç CS; Sestito S; Daştan SD; Kumar M; Alshehri MM; Rapposelli S; Cruz-Martins N; Cho WC
Oxid Med Cell Longev; 2021; 2021():1987588. PubMed ID: 34594472
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the molecular mechanisms and the potential chemopreventive/therapeutic properties of natural compounds in melanoma.
Fontana F; Raimondi M; Di Domizio A; Moretti RM; Montagnani Marelli M; Limonta P
Semin Cancer Biol; 2019 Dec; 59():266-282. PubMed ID: 31233829
[TBL] [Abstract][Full Text] [Related]
13. The Regulation of Endoplasmic Reticulum Stress in Cancer: Special Focuses on Luteolin Patents.
Mohi-Ud-Din R; Mir RH; Wani TU; Alsharif KF; Alam W; Albrakati A; Saso L; Khan H
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458669
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers.
Roy T; Boateng ST; Banang-Mbeumi S; Singh PK; Basnet P; Chamcheu RN; Ladu F; Chauvin I; Spiegelman VS; Hill RA; Kousoulas KG; Nagalo BM; Walker AL; Fotie J; Murru S; Sechi M; Chamcheu JC
Bioorg Chem; 2021 Feb; 107():104595. PubMed ID: 33450548
[TBL] [Abstract][Full Text] [Related]
15. Review of natural compounds for potential skin cancer treatment.
Chinembiri TN; du Plessis LH; Gerber M; Hamman JH; du Plessis J
Molecules; 2014 Aug; 19(8):11679-721. PubMed ID: 25102117
[TBL] [Abstract][Full Text] [Related]
16. Luteolin, a flavonoid with potential for cancer prevention and therapy.
Lin Y; Shi R; Wang X; Shen HM
Curr Cancer Drug Targets; 2008 Nov; 8(7):634-46. PubMed ID: 18991571
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effect of terpenes: focus on malignant melanoma.
Wróblewska-Łuczka P; Cabaj J; Bargieł J; Łuszczki JJ
Pharmacol Rep; 2023 Oct; 75(5):1115-1125. PubMed ID: 37515699
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the molecular mechanism and apoptosis underlying the in-vitro and in-vivo chemotherapeutic efficacy of vanadium luteolin complex in colon cancer.
Roy S; Chakraborty T
Cell Biochem Funct; 2018 Apr; 36(3):116-128. PubMed ID: 29574863
[TBL] [Abstract][Full Text] [Related]
19. Phytochemicals in Skin Cancer Prevention and Treatment: An Updated Review.
Ng CY; Yen H; Hsiao HY; Su SC
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565284
[TBL] [Abstract][Full Text] [Related]
20. Selective synthesis of 7-O-substituted luteolin derivatives and their melanonenesis and proliferation inhibitory activity in B16 melanoma cells.
Yamauchi K; Fujieda A; Mitsunaga T
Bioorg Med Chem Lett; 2018 Aug; 28(14):2518-2522. PubMed ID: 29887353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
